{
    "organizations": [],
    "uuid": "ed41feb3d2783fcdb93f890abfd04b8404c03879",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/us-ftc-impax-laboratories/impax-labs-antitrust-complaint-dismissed-at-federal-trade-commission-idUSKCN1IP2YH",
    "ord_in_thread": 0,
    "title": "Impax Labs antitrust complaint dismissed at Federal Trade Commission",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 24, 2018 / 4:44 PM / Updated 15 minutes ago Impax Labs antitrust complaint dismissed at Federal Trade Commission Reuters Staff 1 Min Read\nWASHINGTON (Reuters) - An administrative law judge at the Federal Trade Commission on Thursday dismissed the agencyâ€™s antitrust complaint against generic drugmaker Impax Laboratories Inc.\nThe agency had alleged that in June 2010 Impax illegally agreed to refrain from marketing for three years a generic version of an extended-release opioid manufactured by Endo Pharmaceuticals ( ENDP.O ), and received more than $112 million in exchange from Endo.\nBut the in-house judge said there was not sufficient proof that the companies violated antitrust laws and that Impax could have manufactured a generic of the painkiller before 2013. Reporting by Lisa Lambert; Editing by Bill Berkrot",
    "published": "2018-05-25T00:44:00.000+03:00",
    "crawled": "2018-05-24T20:09:52.041+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "impax",
        "lab",
        "antitrust",
        "complaint",
        "dismissed",
        "federal",
        "trade",
        "commission",
        "reuters",
        "staff",
        "min",
        "read",
        "washington",
        "reuters",
        "administrative",
        "law",
        "judge",
        "federal",
        "trade",
        "commission",
        "thursday",
        "dismissed",
        "agency",
        "antitrust",
        "complaint",
        "generic",
        "drugmaker",
        "impax",
        "laboratory",
        "agency",
        "alleged",
        "june",
        "impax",
        "illegally",
        "agreed",
        "refrain",
        "marketing",
        "three",
        "year",
        "generic",
        "version",
        "opioid",
        "manufactured",
        "endo",
        "pharmaceutical",
        "received",
        "million",
        "exchange",
        "endo",
        "judge",
        "said",
        "sufficient",
        "proof",
        "company",
        "violated",
        "antitrust",
        "law",
        "impax",
        "could",
        "manufactured",
        "generic",
        "painkiller",
        "reporting",
        "lisa",
        "lambert",
        "editing",
        "bill",
        "berkrot"
    ]
}